NET PROFIT (x1000 EUR)
EMPLOYEES
Billev Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
1,059
|
582
|
851 |
| Total assets |
1,645
|
927
|
1,200 |
| Current assets |
1,645
|
925
|
1,200 |
| Current liabilities |
736
|
339
|
300 |
| Equity capital |
866
|
496
|
706 |
| - share capital |
43
|
43
|
43 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
52.6%
|
53.5%
|
58.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
223.5%
|
272.9%
|
400% |
| Return on equity (ROE) |
122.3%
|
117.3%
|
120.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.